Acrospire Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Acrospire Investment Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-915	Closed	-$54K	–	1583
2017 Q2	$54K	Buy	+915	New	+$47.5K	0.05%	783
2017 Q1	–	Sell	-6,813	Closed	-$358K	–	2573
2016 Q4	$358K	Buy	6,813 +2,463	+57%	+$119K	0.15%	83
2016 Q3	$194K	Buy	4,350 +1,200	+38%	+$52K	0.13%	175
2016 Q2	$120K	Buy	3,150 +300	+11%	+$13.2K	0.09%	309
2016 Q1	$117K	Buy	+2,850	New	+$117K	0.08%	243

Other funds holding SYNH

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Acrospire Investment Management's SYNH Position: Q3 2017 in Review

Acrospire Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2017, closing a stake of 915 shares — an estimated $54K sold.

Acrospire Investment Management first reported a position in SYNH in Q1 2016 and held it in 5 quarters. The position peaked at $358K in Q4 2016. 238 funds tracked by Wall St. Rank hold SYNH as of Q3 2017.

Acrospire Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2017 after selling out during the quarter.
Acrospire Investment Management sold 915 Syneos Health, Inc. Class A Common Stock shares in Q3 2017, an estimated $54K.
Acrospire Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 5 quarters.
Acrospire Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $358K in Q4 2016.
238 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.